News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galderma Canada Inc. Release: First of Its Kind Rosacea Therapy Now Available in Canada



2/27/2013 10:20:27 AM

THORNHILL, ON, Feb. 27, 2013 /CNW/ - Galderma Canada Inc. today announced Apprilon™, an innovative, anti-inflammatory rosacea treatment, is now available for prescription in Canada. Apprilon (Doxycycline Modified-Release Capsule, 40 mg) is the first and only oral, once-daily therapy designed specifically to treat the bumps and pimples associated with rosacea, and does not cause complications associated with long-term antibiotic use.1,2,3

Read at Canada NewsWire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES